Literature DB >> 22390537

"Left at right" adult liver transplantation: the feasibility of heterotopic implantation of left liver graft.

K-M Chan1, F Z Eldeen, C-F Lee, T-J Wu, H-S Chou, T-H Wu, R-S Soong, W-C Lee.   

Abstract

Left liver grafts have been widely utilized in adult liver transplantation (LT) and yielded acceptable results. However, the conventional orthotopic implantation of a left liver graft imposes the potential risk of perioperative vascular complications. We report herein an alternative modified technique for adult left liver LT and evaluate its feasibility in LT. In this study, 10 recipients had their left liver graft rotated 180°, and heterotopically implanted at the right subphrenic space, which we termed "left at right" liver transplantation (LAR-LT). The sequence of vascular and biliary reconstruction was performed as standard techniques, and no perioperative vascular complications related to LAR-LT were encountered. There were two mortalities in this series, one due to a small-for-size graft dysfunction and the other due to postoperative internal hemorrhage. Two recipients had biliary strictures that were successfully managed by percutaneous biliary dilatation and Roux-en-Y hepaticojejunostomy. The clinical characteristics and outcomes of patients undergoing LAR-LT were also compared with patients undergoing conventional orthotopic left liver LT (n = 14). Although the results showed no significant difference between the two groups, according to our experience, the satisfactory outcome and easier technical reconstruction suggest that the LAR-LT modification could be a feasible alternative to left liver LT. © Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2012        PMID: 22390537     DOI: 10.1111/j.1600-6143.2012.03997.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

1.  Clinical strategy for the reconstruction of middle hepatic vein tributaries in right liver living donor liver transplantation.

Authors:  Kun-Ming Chan; Chih-Hsien Cheng; Tsung-Han Wu; Ting-Jung Wu; Hong-Shiue Chou; Ching-Sung Lee; Wei-Chen Lee
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

2.  A panel of biomarkers in the prediction for early allograft dysfunction and mortality after living donor liver transplantation.

Authors:  Hsin-I Tsai; Chi-Jen Lo; Chao-Wei Lee; Jr-Rung Lin; Wei-Chen Lee; Hung-Yao Ho; Chia-Yi Tsai; Mei-Ling Cheng; Huang-Ping Yu
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

Review 3.  Living donor liver transplantation: where do we stand and where are we going?

Authors:  Hao Lu; Ling Lu; Feng Zhang; Yuan Zhai; Xuehao Wang
Journal:  Hepatobiliary Surg Nutr       Date:  2016-04       Impact factor: 7.293

4.  A Comparison between splenic fossa and subhepatic fossa auxiliary partial heterotopic liver transplantation in a porcine model.

Authors:  Lemin Ai; Xiao Liang; Zhifei Wang; Jie Shen; Feiyan Yu; Limei Xie; Yongming Pan; Hui Lin
Journal:  Liver Transpl       Date:  2016-06       Impact factor: 5.799

5.  "Left at right" liver transplantation with heterotopic implantation of left liver graft in the right subphrenic space: Reappraisal and technical concerns for decision making.

Authors:  Kun-Ming Chan; Chih-Hsien Cheng; Tsung-Han Wu; Chen-Fang Lee; Ting-Jung Wu; Hong-Shiue Chou; Wei-Chen Lee
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

6.  Encouraging Split Liver Transplantation for Two Adult Recipients to Mitigate the High Incidence of Wait-list Mortality in The Setting of Extreme Shortage of Deceased Donors.

Authors:  Kun-Ming Chan; Yu-Chao Wang; Tsung-Han Wu; Chih-Hsien Cheng; Chen-Fang Lee; Ting-Jung Wu; Hong-Shiue Chou; Wei-Chen Lee
Journal:  J Clin Med       Date:  2019-12-01       Impact factor: 4.241

7.  A nomogram for prediction of early allograft dysfunction in living donor liver transplantation.

Authors:  Yu-Chen Ko; Hsin-I Tsai; Chao-Wei Lee; Jr-Rung Lin; Wei-Chen Lee; Huang-Ping Yu
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.